Intercell AG | Company profile from Hoover's
 
Call Now! 866-464-3202
This is a custom template (Home Pages: Video Center Area - AUTO PLAY WITH MUTED SOUND) that is currently displayed on the following pages: * third column

Video Center

Intercell AG · Vienna Austria(Vienna: ICLL)

Company Description

Campus Vienna Biocenter 3
Vienna
1030
Austria (Map)
Phone: +43-1-20620-0
Fax: +43-1-20620-800
    View Intercell AG Locations On A US MapThis link will open in a new window
    Intercell AG really wants give the pharmaceutical industry a shot in the arm. The Austrian company develops new vaccinations that aim to invoke strong immune system responses. It sells a travelers vaccine for Japanese encephalitis in areas of Europe, the Asia/Pacific region, and North America. Vaccine development candidates aim to fight staph infections, pandemic influenza, hepatitis C, and other viral and bacterial infections. The company also develops antibody (protein) therapies. Intercell has commercial licensing and co-development agreements with larger companies, including Novartis, Sanofi-Aventis, and MerckTo read the full description, subscribe now.
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!

    Intercell AG Reports

    No subscription, no problem.
    Download presentation-ready reports for this company now.
    From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.

    Key Intercell AG Financials

    Company TypePublic - Vienna: ICLL

    Headquarters
    Fiscal Year-EndDecember
    2008 Employees400

    Intercell AG Executives

    14 executives listed for Intercell AG's Vienna Austria location.
    TitleName & BioContact
    ChairmanMichel GrécoEmail
    Vice ChairmanErnst-Günter AftingEmail
    CEOGerd ZeittlmeisslEmail

    Competition

    Competitive Landscape for Intercell AG
    Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.
    Top Intercell AG Competitors
    Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!